Local earnings

Several companies with Utah ties reported quarterly financial results Tuesday.

Usana

Salt Lake-based Usana Health Sciences Inc. reported net income of $9.6 million, or 50 cents per share, for the quarter ended April 1. That compares with $8.9 million, or 45 cents per share, for the first quarter a year earlier.

Usana said earnings from operations were affected by $947,000 in expensing of equity-based compensation. That equates to 3 cents per share.

Sales were a company-record $89.7 million, up from $76.6 million a year earlier.

Usana said it expects net sales of $92 million to $94 million and earnings per share between 54 cents and 56 cents in the fiscal second quarter, excluding equity-based compensation expensing. With that adjustment, earnings per share are expected to be 51 cents to 53 cents.

Usana develops and manufactures nutritionals, personal care and weight management products.

Usana stock rose $1.10 Tuesday to close at $41.79 per share on Nasdaq. During the past year, the price has ranged from $37.30 to $54.10.

Parker Hannifin

Parker Hannifin Corp., the world's largest maker of hydraulic equipment, said fiscal third-quarter profit rose 27 percent, helped by demand for aerospace products.

Net income rose to $177.5 million, or $1.46 a share, from $139.4 million, or $1.15, a year earlier, the Cleveland-based company said. Sales rose 18 percent to $2.5 billion.

Parker Hannifin's Ogden facility manufactures hydraulic systems for commercial aircraft.

Parker Hannifin stock rose $4.56 Tuesday to close at $83.83 per share on the New York Stock Exchange. During the past year, the price has ranged from $57.32 to $83.39.

Boston Scientific

Heart device maker Boston Scientific Corp. said first-quarter earnings fell 7.3 percent on lower sales of drug-coated stents and costs for an aborted gene therapy experiment.

Net income declined to $332 million, or 40 cents a share, from $358 million, or 42 cents, a year earlier, said the company, based in Natick, Mass. Revenue was little changed at $1.62 billion.

Excluding certain costs, first-quarter profit rose to 46 cents a share from 42 cents a year earlier. A Thomson Financial survey of 15 analysts found an average estimate of 46 cents.

Last summer, the company acquired Salt Lake-based Rubicon Medical Corp.

Boston Scientific stock rose 26 cents Tuesday to close at $21.74 per share on the NYSE. During the past year, the price has ranged from $20.57 to $31.32.

---

Contributing: Bloomberg News